The prognosis of COVID-19 is largely dependent on various factors that include the severity of illness at presentation, associated underlying co-morbid conditions, and response to treatment. Based on a large cohort study from China involving 44415 patients, a vast majority (81%) were diagnosed with mild illness and had a favorable clinical course. The other 19 % were diagnosed with severe to critical illness requiring hospitalization, of which 5% developed critical illness characterized by respiratory failure and multiorgan dysfunction